JP2005526103A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526103A5
JP2005526103A5 JP2003581749A JP2003581749A JP2005526103A5 JP 2005526103 A5 JP2005526103 A5 JP 2005526103A5 JP 2003581749 A JP2003581749 A JP 2003581749A JP 2003581749 A JP2003581749 A JP 2003581749A JP 2005526103 A5 JP2005526103 A5 JP 2005526103A5
Authority
JP
Japan
Prior art keywords
powder preparation
suspension
tiotropium
physiologically acceptable
acceptable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003581749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526103A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/003253 external-priority patent/WO2003084509A1/en
Publication of JP2005526103A publication Critical patent/JP2005526103A/ja
Publication of JP2005526103A5 publication Critical patent/JP2005526103A5/ja
Pending legal-status Critical Current

Links

JP2003581749A 2002-04-04 2003-03-28 吸入に適した粉末製剤 Pending JP2005526103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007634 2002-04-04
PCT/EP2003/003253 WO2003084509A1 (en) 2002-04-04 2003-03-28 Powder formulations suitable for inhalation

Publications (2)

Publication Number Publication Date
JP2005526103A JP2005526103A (ja) 2005-09-02
JP2005526103A5 true JP2005526103A5 (enExample) 2006-05-25

Family

ID=28685839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003581749A Pending JP2005526103A (ja) 2002-04-04 2003-03-28 吸入に適した粉末製剤

Country Status (19)

Country Link
US (2) US6881422B2 (enExample)
EP (1) EP1494648B1 (enExample)
JP (1) JP2005526103A (enExample)
KR (1) KR101007151B1 (enExample)
CN (1) CN100360116C (enExample)
AT (1) ATE339951T1 (enExample)
AU (1) AU2003221531B2 (enExample)
BR (1) BR0308984A (enExample)
CA (1) CA2479919C (enExample)
DE (1) DE60308497T2 (enExample)
DK (1) DK1494648T3 (enExample)
ES (1) ES2272968T3 (enExample)
IL (2) IL163736A0 (enExample)
MX (1) MXPA04009583A (enExample)
NZ (1) NZ536277A (enExample)
PL (1) PL207752B1 (enExample)
RU (1) RU2004132222A (enExample)
WO (1) WO2003084509A1 (enExample)
ZA (1) ZA200406911B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0107304A (pt) 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
CN102070630B (zh) 2003-11-03 2013-04-17 贝林格尔.英格海姆国际有限公司 结晶噻托碘铵、包含该结晶噻托碘铵的药物制剂及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
DK1131059T3 (da) * 1998-11-13 2003-06-30 Jago Res Ag Tørpulver til inhalation
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
BR0107304A (pt) * 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6482429B1 (en) * 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen

Similar Documents

Publication Publication Date Title
CN1123142A (zh) 氟西汀药物制剂
EP2388017B1 (en) Catalytic radiofluorination
BR112014026292B1 (pt) Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
HRP20100029T1 (hr) Novi kristalinični anhidrid s antiholinergičkim učinkom
TW201729812A (zh) 一種含有jak激酶抑制劑或其可藥用鹽的醫藥組成物
JP2005526103A5 (enExample)
KR101222373B1 (ko) 녹점토 분산성 정제 및 그 제조
RU2007117499A (ru) Фармацевтические композиции, маскирующие вкус
KR20140019445A (ko) 호흡기 질환에 작용하는 복합 화학 약물, 그들의 제조 방법 및 용도
RU2004132222A (ru) Порошковые композиции, пригодные для ингаляции
JP5721093B2 (ja) 崩壊錠
PT1928459E (pt) Preparação de libertação retardada na forma de comprimidos contendo cinarizina e dimenidrinato contra a vertigem
CN103301467A (zh) 一种稳定的掩味的盐酸氨溴索复合物及其制备方法
JP2010501520A5 (enExample)
JP2012072061A (ja) 新規組成物
Křikava et al. The effects of lidocaine on bupivacaine-induced cardiotoxicity in the isolated rat heart
JP2008007523A (ja) 固形重曹透析用剤
CN106880611A (zh) 一种含微粉化的托伐普坦和水溶性辅料的托伐普坦制剂
CN102258504A (zh) 一种复方硫酸沙丁胺醇和盐酸氨溴索吸入溶液
CN111228228A (zh) 一种抗病毒化合物的组合物及其制备方法
CN108721238A (zh) 一种碳酸锂缓释片
PT1646373E (pt) Composição farmacêutica orodispersível de um composto antitrombótico
CN105168245A (zh) 一种氟化钠缓释片的制备方法及用途
JP4062719B2 (ja) 固形重曹透析用剤およびその製造方法
CN109223723B (zh) 吡非尼酮片剂及其制备方法和用途